MetLife, Inc.
Every calculator, already run for MET
Open the full toolkit →You have the numbers on MET. Get the argument.
A written report on which of these readings actually decide the outcome for MetLife, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
18 analysts covering METAnalyst Price Target Disagreement for MetLife, Inc.
Wall Street's bull case implies +23% from the current price; the bear case implies -13%. A 36% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About MetLife, Inc.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rat…
MET — frequently asked
Is MET a buy right now?
Wall Street's consensus rating on MetLife, Inc. is Buy across 18 analysts, with a mean price target of $103.88 (+7% vs. the current $96.68). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is MET overvalued?
MET trades at 18.5x trailing earnings. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
What is the analyst price target disagreement for MetLife, Inc.?
Analysts covering MetLife, Inc. (MET) range from a bear-case target of $84.00 to a bull-case high of $119.00, with a mean consensus target of $103.88 across 16 analysts. The spread of $35.00 (36% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare MetLife, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For MetLife, Inc.
Start with the evergreen guides that matter most for Financial Services, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full MET research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on MetLife, Inc., in minutes. 3 free reports included with every account — no credit card required.